Panacea NeuroGen

Neurogenesis is at the core of everything we create. Panacea NeuroGen delivers neuroregenerative biologics as pharmaceutical answers to many of todays most concerning medical diagnoses.  

Panacea NeuroGen's initial focus is a regenerative non-opioid pain therapy. However, Panacea innovation spans numerous medical diagnoses focusing on neurodegenerative disease of the central and autonomic nervous systems backed by four decades of translational research in the biochemical center of health and the brain, known as the sympathetic and central nervous systems.  

Many today know the sympathetic nervous system for managing the stress response, or commonly called "fight - flight - fawn - freeze" now a broad conversation on many social media platforms. Panacea pioneered that conversation beginning 2006 after decades of research and development, delivering much needed awareness, and answers that became a tidal wave of passion for so many suffering.  

The impact of stressors on physical and emotional health, mental illness and physical disease are now commonly understood to be biologically aligned. And we understand those answers by our commitment of nearly 40 years research and pioneering neuroregenerative work in nervous systems and organ structures.  

Panacea NeuroGen treatments have been developed with specific focus on neuroregeneration, (called neurogenesis by science) in the patient, with special emphasis on sensitive patients, understanding that 60% of patients are sensitive and that 60% of the United States population have a chronic illness or disease diagnosis.  

We know this is not a coincidence. We know as you do that methods traditionally used to create drugs have not risen to a standard we urgently require.

Further, we know that if we can successfully treat the most sensitive we readily succeed for the most robust.

And so we remind you that Panacea is founded on regeneration of nervous systems, not a business opportunity - YOU Are The Reason.